About this episode
In today's views
- Strategy | Reiterating small-cap pharma call: Nile Pharma bubble crashed and Memphis Pharma will likely outperform in 2026
- MFPC roundtable takeaways | Structural export advantage reinforced, limited CBAM risk, and clear investment path ahead
- CICH | 9M25 resilience underscores our EGP13/share fair value
- TWSA | Preliminary indicators show promising growth in factoring
Get every episode summarized
Each time Al Ahly Pharos publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Al Ahly Pharos
Technical Analysis 10 September 2026
Al Ahly Pharos
Sep 10, 20266:32skipped_language
Technical Analysis 9 September 2026
Al Ahly Pharos
Sep 9, 202610:00skipped_language
Technical Analysis 8 September 2026
Al Ahly Pharos
Sep 8, 20267:39pending
Technical Analysis 7 September 2026
Al Ahly Pharos
Sep 7, 202610:09skipped_language